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G protein signaling pathways, as key components of
physiologic responsiveness and timing, are frequent
targets for pharmacologic intervention. Here, we
identify an effector for heterotrimeric G protein a
subunit (EhGa1) signaling from Entamoeba histoly-
tica, the causative agent of amoebic colitis. EhGa1
interacts with this effector and guanosine triphos-
phatase-accelerating protein, EhRGS-RhoGEF, in
a nucleotide state-selective fashion. Coexpression
of EhRGS-RhoGEF with constitutively active EhGa1
and EhRacC leads to Rac-dependent spreading in
DrosophilaS2 cells. EhRGS-RhoGEF overexpression
in E. histolytica trophozoites leads to reduced migra-
tion toward serum and lower cysteine protease
activity, as well as reduced attachment to, and
killing of, host cells. A 2.3 A˚ crystal structure of
the full-length EhRGS-RhoGEF reveals a putative
inhibitory helix engaging the Dbl homology domain
Rho-binding surface and the pleckstrin homology
domain. Mutational analysis of the EhGa1/EhRGS-
RhoGEF interface confirms a canonical ‘‘regulator
of G protein signaling’’ domain rather than a Rho-
GEF-RGS (‘‘rgRGS’’) domain, suggesting a conver-
gent evolution toward heterotrimeric and small G
protein cross-talk.
INTRODUCTION
Heterotrimeric G protein signaling pathways are frequent tar-
gets for pharmacologic manipulation (Gilchrist, 2007). The Ga
subunit in its inactive, guanosine diphosphate (GDP)-bound con-
formation engages the obligate Gbg dimer (Oldham and Hamm,
2008). A ligand-activated seven-transmembrane G protein-
coupled receptor promotes nucleotide exchange on the Ga
subunit. Upon binding of guanosine triphosphate (GTP) by theStructure 21Ga subunit, three switch regions undergo a conformational
change, leading to separation from Gbg and subsequent activa-
tion of downstream effectors, such as adenylyl cyclases, phos-
pholipase C, and Rho-family guanine nucleotide exchange
factors (RhoGEFs) (Aittaleb et al., 2010; Oldham and Hamm,
2008). Signaling is terminated by the guanosine triphosphatase
(GTPase) activity of the Ga subunit and reassembly of the
Ga$GDP/Gbg heterotrimer.
‘‘Regulator of G protein signaling’’ (RGS) proteins accelerate
the intrinsic GTP hydrolysis activity of Ga subunits and thereby
serve as negative regulators of signaling (Kimple et al., 2011).
Canonical nine-helix RGS domains exhibit highest affinity for
Ga in its transition-state mimetic form, stabilizing the switch
regions for efficient hydrolysis (Tesmer et al., 1997). Members
of the RGS-RhoGEF family of Ga effectors contain N-termini
with similarity to RGS domains (called ‘‘RhoGEF-RGS’’ or
‘‘rgRGS’’ domains), in combination with Dbl homology (DH)
and pleckstrin homology (PH) domains that together mediate
activation of Rho family GTPases (Aittaleb et al., 2010). The DH
domain engages substrate Rho GTPases, promoting nucleotide
release, while the PH domain frequently modulates exchange in
various Dbl-family RhoGEF members (Rossman and Sondek,
2005). In contrast to nine-helix RGS domains, rgRGS domains
have a distinct 12-helix fold and engage Ga12/13 subunits
through an effector-like interface involving primarily switch 2
and the a3 helix (Aittaleb et al., 2010). An N-terminal extension
of the rgRGS domain containing an ‘‘IIG’’ sequence motif
contacts the Ga12/13 switch regions and all-helical domain and,
in the case of p115 RhoGEF, is required for GTPase accelerating
protein (GAP) activity toward Ga12/13 subunits. Although struc-
tures of RGS-RhoGEFs with both the rgRGS and DH-PH domain
tandems have not yet been elucidated, p115 RhoGEF is thought
to be activated by an allosteric ‘‘GEF switch’’ mechanism that
involves a conformational change of an N-terminal extension of
the DH domain (Chen et al., 2011). Recent low-resolution struc-
tural studies of full-length p115 RhoGEF suggest an elongated
domain architecture and a potential bimodal interaction with
Ga13, namely the effector interface with the rgRGS domain
and a potential additional interface with the DH domain (Chen
et al., 2012). The activation mechanism of another mammalian, 65–75, January 8, 2013 ª2013 Elsevier Ltd All rights reserved 65
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EhRGS-RhoGEF Acts to Control Amoebic PathogenesisRGS-RhoGEF, PDZ-RhoGEF, is thought to be complex, in-
volving disruption of an electrostatic RGS-DH linker and DH
domain interaction, perturbation of a putative RGS-DH linker
‘‘molten globule,’’ and membrane recruitment, as well as a
‘‘GEF switch’’ (Bielnicki et al., 2011; Zheng et al., 2009). Low-
resolution small-angle X-ray scattering (SAXS) studies of PDZ-
RhoGEF also suggested an ensemble of elongated domain
architectures (Bielnicki et al., 2011).
Entamoeba histolytica causes an estimated 50 million infec-
tions and 100,000 deaths per year worldwide, with highest inci-
dence in countries with poor barriers between drinking water
and sewage (WHO, 1997). Following ingestion of encysted
E. histolytica, the trophozoite or amoeboid form of the parasite
attaches to and destroys intestinal epithelial cells, giving rise to
amoebic colitis (Ralston and Petri, 2011). Although themolecular
details of signaling pathways in E. histolytica remain under-
studied, a relatively large family of Rho GTPases and Dbl family
RhoGEFs are known to modulate cytoskeletal dynamics, as well
as key pathogenic processes, such as trophozoite migration,
extracellular matrix invasion, and killing and phagocytosis of
host cells (Bosch et al., 2011a; Guille´n, 1996; Meza et al., 2006).
Recently, we identified a functional heterotrimeric G protein
signaling pathway in E. histolytica; perturbation of the Ga sub-
unit, EhGa1, elucidated positive regulatory roles for G protein
signaling in pathogenic processes, such as trophozoite migra-
tion and invasion, host cell attachment, and cell killing (Bosch
et al., 2012). Overexpression of eitherwild-typeEhGa1or a domi-
nant negative mutant in E. histolytica trophozoites resulted in
altered transcription of numerous genes that have implicated
multiple potential mechanisms by which G protein signaling
modulates pathogenesis. From this study, a set of Rho GTPase
signaling proteins, including an RGS-RhoGEF, and actin-associ-
ated proteins was observed to be differentially transcribed
downstream of heterotrimeric G-proteins (Table S1 available on-
line). We hypothesized that EhRGS-RhoGEF, like its mammalian
homologs, serves as an EhGa1 effector and signals through Rho
family GTPases, with important roles in Entamoeba histolytica
pathogenesis. Here our results describe EhRGS-RhoGEF as an
effector and GAP of EhGa1, with importance for E. histolytica
motility, host cell attachment, cell killing, and cysteine protease
secretion. Activation of EhRGS-RhoGEF by coexpression of
constitutively active EhGa1 and EhRacC leads to Rac family
GTPase-dependent cell spreading in Drosophila S2 cells. Fur-
thermore, we provide a crystal structure of the full-length
RGS-RhoGEF in the inactive state, elucidating its molecular
architecture and likely distinct evolutionary origin relative to the
mammalian RGS-RhoGEFs.
RESULTS
EhGa1 Engages an RGS-RhoGEF Effector and GTPase
Accelerating Protein
The E. histolytica genome encodes a single classical Ga sub-
unit effector, an RGS domain-containing RhoGEF (GenBank
XP_653063; named EhRGS-RhoGEF) with distant similarity to
the RGS-RhoGEF effectors of mammalian Ga12/13 subunits (Fig-
ure S1). Transcription of EhRGS-RhoGEF was seen to be upre-
gulated upon overexpression of EhGa1 in E. histolytica tropho-
zoites, suggesting a functional link to heterotrimeric G protein66 Structure 21, 65–75, January 8, 2013 ª2013 Elsevier Ltd All rightssignaling (Table S1). EhRGS-RhoGEF was purified from E. coli
(Figure S2) and found to bind directly to EhGa1 selectively in
its GDP$AlF4
 (AMF) nucleotide state, as measured by surface
plasmon resonance (Figures 1A–1D). Reciprocal immobilization
experiments each indicated an 5 mM EhGa1$AMF/EhRGS-
RhoGEF dissociation constant (KD). EhRGS-RhoGEF also inter-
acted with the constitutively active, GTPase-deficient EhGa1
(Q189L) mutant in its GTP-bound form, although with 20-fold
lower affinity than for EhGa1$AMF (KD z 110 mM) (Figure 1B).
The EhGa1(Q189L)$GTP/EhRGS-RhoGEF binding affinity could
not be precisely determined by equilibrium binding analysis,
due to concentration limitations of our assay. The preference
of EhRGS-RhoGEF for the AMF nucleotide state over the GTP-
bound state of EhGa1 is consistent with a similar order-of-
magnitude difference in p115 RhoGEF affinity for Gai1/13$AMF
compared to Gai1/13$GTPgS (Chen et al., 2005). To determine
whether the interaction occurs through the RGS domain of
EhRGS-RhoGEF, a conserved glutamate at the predicted Ga
subunit-binding surface wasmutated to lysine (E39K; Figure S1).
Despite proper global folding of the E39K mutant (Figure S2B), it
exhibited drastically reduced affinity for EhGa1$AMF (Figure 1D).
The isolated RGS domain of EhRGS-RhoGEF could not be
produced from E. coli. However, the RGS domain expressed in
HEK293T cells was seen to specifically coprecipitate with puri-
fied EhGa1$AMF and EhGa1(Q189L)$GTP, but not EhGa1$GDP
(Figure S2C), suggesting that the RGS domain alone is sufficient
to bind EhGa1.
The relatively high affinity of wild-type EhRGS-RhoGEF for
the hydrolysis transition state-mimetic (AMF) form of EhGa1
suggested that the RGS domain of EhRGS-RhoGEF may serve
as a GAP for EhGa1. Interestingly, EhRGS-RhoGEF lacks the
N-terminal extension containing the IIG motif that is required
for the GAP activity of p115 RhoGEF (Figure S1; Aittaleb et al.,
2010). However, single turnover GTP hydrolysis assays demon-
strated that wild-type EhRGS-RhoGEF, but not the EhRGS-
RhoGEF(E39K) mutant, accelerates the intrinsic GTP hydrolysis
activity of EhGa1 in a concentration-dependent fashion (Fig-
ure 1E). Mutation of the conserved Asn-83 in the EhRGS-
RhoGEF RGS domain, predicted to contact and orient EhGa1
switch residues for efficient catalysis of GTP hydrolysis (Tesmer
et al., 1997), also eliminated GAP activity (Figure 1F) and
dramatically reduced EhRGS-RhoGEF/EhGa1 binding affinity
(Figure 1C).
EhGa1 and EhRacC Activate EhRGS-RhoGEF to
Promote Rho-Dependent Cell Spreading
To determine the ability of EhRGS-RhoGEF to modulate Rho-
dependent cellular processes and its potential regulation by
EhGa1, we utilized Drosophila S2 cells that undergo a dramatic
morphological transition with distinctive reorganization of actin
structures when Rho family GTPases are activated by various
stimuli (Rogers et al., 2003). For example, overexpression of a
GTPase-deficient and constitutively active D.m. Rac1(G14V)
leads to cell spreading in80%ofS2 cells on a polylysine coated
surface, as compared to 20% of cells expressing red fluores-
cent protein (Figures 2A and 2B). Expression of constitutively
active EhGa1(Q189L) and EhRGS-RhoGEF was not sufficient to
significantly increase cell spreading.However, additional expres-




Figure 1. EhRGS-RhoGEF Is an EhGa1 Effector that Accelerates Its GTP Hydrolysis
(A–D) Either EhGa1 or EhRGS-RhoGEF was immobilized on a surface plasmon resonance chip and the complementary protein flowed over at increasing
concentrations. EhRGS-RhoGEF bound EhGa1 selectively in the GDP$AlF4
-bound state (AMF); interaction affinity was independent of immobilized species ([B]
KD = 5.2 ± 0.8 mM; [D] 5.7 ± 1.6 mM). The GTPase-deficient mutant EhGa1(Q189L) also interacted with EhRGS-RhoGEF, but with lower affinity (KDz 110 mM).
Mutation of the conserved EhRGS-RhoGEF Asn-83, predicted to orient EhGa1 residues for rapid GTP hydrolysis, the predicted EhGa1-binding surface charge
reversal EhRGS-RhoGEF(E39K), and the switch 1 mutant EhGa1(G168S) all drastically reduced binding affinity. Sensorgrams and equilibrium binding curves are
representative of three experiments.
(E and F) The GTPase rate of EhGa1 was accelerated by EhRGS-RhoGEF in a dose-dependent fashion (kobs = 0.20 ± 0.02 min
1 for EhGa1 alone and 1.45 ±
0.13 min1 upon addition of 25 mM EhRGS-RhoGEF). EhRGS-RhoGEF(E39K) and EhRGS-RhoGEF(N83A) had no effect on the hydrolysis rate.
(G) GTP hydrolysis rates for the ‘‘RGS-insensitivity’’ mutant EhGa1(G168S) alone or in the presence of a high concentration of EhRGS-RhoGEF were indistin-
guishable. Error bars represent standard error of the mean for duplicate reactions. Each single turnover hydrolysis experiment was independently repeated at
least twice.
Figure S2 indicates proper folding of the EhRGS-RhoGEF(E39K) mutant and nucleotide state-specific binding of EhGa1 to the isolated RGS domain.
Structure
EhRGS-RhoGEF Acts to Control Amoebic Pathogenesissuggesting that GTP-bound EhGa1 and EhRacC are necessary
to activate EhRGS-RhoGEF. Importantly, EhRacC(Q65L) alone
(not shown) or in combination with EhGa1 (Figure 2) did not
trigger S2 cell spreading, indicating its inability to productively
engage the endogenous D.m. Rho GTPase signaling machinery
independently of EhRGS-RhoGEF.Wild-typeEhGa1did not acti-
vate EhRGS-RhoGEF, and the EhRGS-RhoGEF(E39K) mutation
prevented an increase in cell spreading (Figures 2A and 2B).
Thus, coexpression of EhRGS-RhoGEF with constitutively active
EhRacC and interaction with constitutively active EhGa1 at the
RGS domain are required for enhanced cell spreading.Structure 21The observed cell-spreading phenotype strongly suggested
that EhRGS-RhoGEF was signaling through endogenous
Drosophila Rho family GTPases. To investigate the dependence
of the observed phenotype on endogenous Rho family GTPases,
we knocked down expression ofD.m.Rac1/2 (both isoforms tar-
geted), Rho, and mtl by RNA interference, as demonstrated
previously in S2 cells (Rogers and Rogers, 2008). Specific knock
down of D.m. Rac GTPases abolished the cell-spreading effect
of EhRGS-RhoGEF, EhGa1(Q189L), and EhRacC(Q65L), sug-
gesting that either or both D.m. Rac isoforms may serve as
substrates for overexpressed EhRGS-RhoGEF (Figure 2A)., 65–75, January 8, 2013 ª2013 Elsevier Ltd All rights reserved 67
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Figure 2. EhRGS-RhoGEF Activation by Constitutively Active EhGa1 and EhRacC Leads to Rac-Dependent S2 Cell Spreading
(A–C) Rho family GTPase activation in D. melanogaster S2 cells leads to spreading on a polylysine coated surface (Rogers and Rogers, 2008). Coexpression of
EhRGS-RhoGEF with GTPase-deficient and constitutively active EhGa1(Q189L) was insufficient to effect cell spreading. However, expression of the constitu-
tively active EhRacC(Q65L) together with EhGa1(Q189L) and EhRGS-RhoGEF significantly enhanced cell spreading, while EhRacC(Q65L) alone or in combi-
nation with EhGa1 had no effect. To determine which D. melanogaster Rho family GTPases were necessary for cell spreading, and thus potential substrates for
overexpressed EhRGS-RhoGEF, double-stranded RNAi was employed as described previously (Rogers et al., 2003). RNAi-mediated knockdown of D.m. Rac
isoforms, but not Rho ormtl, prevented significant enhancement of cell spreading by coexpression of EhRGS-RhoGEF, EhRacC(Q65L), and EhGa1(Q189L). Error
bars represent standard deviation for three independent experiments, and * indicates statistically significant difference (p < 0.05) by Student’s t test. Example
micrographs are shown in (B) and western blots confirming expression of all E. histolytica proteins and mutants are shown in (C).
(D) Recombinant, activated EhRacC(Q65L)$GTP was seen to directly bind EhRGS-RhoGEF by surface plasmon resonance, while EhRacC$GDP and nucleotide-
free EhRacC exhibited negligible binding up to 40 mM concentration.
Figure S1 contains sequence alignments of EhRGS-RhoGEF and mammalian homologs.
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EhRGS-RhoGEF Acts to Control Amoebic PathogenesisTo test whether activated EhRacC directly engages EhRGS-
RhoGEF, surface plasmon resonance was utilized. EhRGS-
RhoGEF selectively bound EhRacC(Q65L)$GTP, to the exclusion
of EhRacC$GDP or nucleotide-free EhRacC (Figure 4D). This
pattern of nucleotide state selectivity was consistent with a
Rho GTPase and effector-like interaction, rather than a RhoGEF
and substrate Rho GTPase relationship. Although the observed
recombinant EhRacC(Q65L)/EhRGS-RhoGEF affinity was rela-
tively low (KD z 34 ± 9 mM), the cell-spreading experiments
suggest that a productive interaction occurs in a cellular context.
The interaction of EhRGS-RhoGEF with an active species of Rho
family GTPase was reminiscent of the structurally elucidated
interaction between human RhoA$GTPgS and a hydrophobic
patch on the PH domain of PDZ-RhoGEF (Chen et al., 2010b).
An analysis of the PDZ-RhoGEF PH domain residues involved
in activated RhoA binding (Protein Data Bank [PDB] 3KZ1) re-68 Structure 21, 65–75, January 8, 2013 ª2013 Elsevier Ltd All rightsvealed poor conservation with the corresponding PH domain
residues of EhRGS-RhoGEF (19% identity, 25% similarity);
thus, we do not predict that EhRacC$GTP binds EhRGS-
RhoGEF in a similar fashion. However, a direct interaction does
occur between activated EhRacC and EhRGS-RhoGEF, poten-
tially explaining the required coexpression of EhRacC(Q65L),
together with EhGa1(Q189L) and EhRGS-RhoGEF to enhance
cell spreading (Figures 2A and 2B).
EhRGS-RhoGEF Modulates Pathogenic Processes of
E. histolytica Trophozoites
We next investigated the role(s) of RGS-RhoGEF signaling in
E. histolytica trophozoites by engineering the virulent HM-
1:IMSS strain to stably overexpress wild-type EhRGS-RhoGEF
(Figure 3). We focused on measuring the effect of EhRGS-
RhoGEF overexpression on trophozoite chemotactic migration,reserved
A B
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Figure 3. EhRGS-RhoGEF Expression In-
hibits Host Cell Attachment and Killing,
Cysteine Protease Secretion, and Chemo-
tactic Migration by E. histolytica Tro-
phozoites
(A) Amoebae were stably transfected to over-
express EhRGS-RhoGEF (inset). Expression of
EhRGS-RhoGEF reduced theability ofE. histolytica
to kill Jurkat (human lymphocyte-derived) cells
compared to the HM-1:IMSS virulent parent strain,
as determined by a membrane integrity assay.
(B) Trophozoites expressing EhRGS-RhoGEF ex-
hibited reduced cysteine protease secretion, a
process necessary for host cell killing and extra-
cellular matrix invasion.
(C) Overexpression of RGS-RhoGEF reduced tro-
phozoite chemotactic migration across a porous
membrane toward serum-containing nutritive
media, but had no measureable effect on random
migration.
(D) Trophozoites attach to CHO cell monolayers,
primarily through a galactose-inhibitable lectin.
Overexpression of EhRGS-RhoGEF reduced lec-
tin-dependent monolayer attachment. All tropho-
zoite experiments were conducted in quadrupli-
cate. Error bars represent standard error of the
mean. * indicates a statistically significant differ-
ence by Student’s t test (p < 0.05).
Table S1 indicates transcriptional regulation
of EhRGS-RhoGEF in amoebae overexpressing
EhGa1 and mutants.
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EhRGS-RhoGEF Acts to Control Amoebic Pathogenesishost cell attachment, and cell killing, given the known depen-
dence of these vital pathogenic processes on actin cytoskeletal
dynamics, as well as Rho GTPases and Dbl family RhoGEFs
(Guille´n, 1996; Meza et al., 2006). Trophozoites ectopically over-
expressing EhRGS-RhoGEF killed host cells less efficiently than
the parent strain, as indicated by a membrane integrity assay
(Figure 3A). A number of cytotoxic proteins are involved in host
cell killing, including membrane-perforating amoebapores and
cysteine proteases (Ralston and Petri, 2011). Reduced secretion
of active cysteine proteases, as measured by an azo-collagen
assay (Figure 3B), may account in part for the impaired cell killing
of the EhRGS-RhoGEF-expressing trophozoite strain. Direct
attachment of E. histolytica trophozoites to host epithelial cells,
primarily through a galactose-inhibitable lectin (Petri et al.,
2002), is also required for tissue destruction. Amoebae over-
expressing EhRGS-RhoGEF showed reduced attachment to
Chinese hamster ovary (CHO) cell monolayers compared to
the parent strain (Figure 3D). E. histolytica trophozoites are
also highly motile, a feature that is dependent on a dynamic actin
cytoskeleton regulated by Rho family GTPase signaling (Meza
et al., 2006). Transwell migration experiments indicated that
overexpression of EhRGS-RhoGEF also decreases trophozoite
chemotactic migration toward serum, but not random migration
(Figure 3C), suggesting that interfering with the EhGa1/EhRGS-
RhoGEF signaling axis modulates the E. histolytica migratory
response to serum factors.
A Crystal Structure of EhRGS-RhoGEF
While isolated domains from mammalian RGS-RhoGEFs have
been structurally characterized (Aittaleb et al., 2010), a high-
resolution structure of an RGS domain together with a DH-PHStructure 21domain tandem has not been elucidated to date. We obtained
a crystal structure of a nearly full-length EhRGS-RhoGEF protein
(lacking only two residues from each terminus) to 2.3 A˚ by single
wavelength anomalous dispersion (SAD) (Table 1). The structural
model exhibits an N-terminal, canonical nine-helix RGS domain,
an oblong DH domain, and a C-terminal PH domain (Figure 4A).
The RGS domain interacts with the DH domain surface opposite
from the PH domain and the putative Rho GTPase binding site
(Figure 4). The linker between the RGS and DH domains wraps
around the oblong helical bundle of the DH domain (Figure 4A),
forming an additional helix (termed the ‘‘inhibitory helix’’).
The RGS domain of EhRGS-RhoGEF is involved in multiple
crystal contacts (Figure S5); specifically, the putative Ga-bind-
ing surfaces of neighboring EhRGS-RhoGEF molecules in the
crystal lattice contact one another. Although crystal contacts
maymodestly affect the disposition of the RGS domain, the simi-
larity of its conformation to mammalian RGS domains in both
crystallographic and nuclear magnetic resonance studies (Fig-
ure 6B; Soundararajan et al., 2008) and significant burial of
hydrophobic surface area (850 A˚2) at the RGS-DH domain
interface suggest that the crystal structure architecture accu-
rately reflects that of EhRGS-RhoGEF in solution.
The PH domain exhibits a conserved overall fold despite
weak sequence similarity (2.9 A˚ root-mean-square deviation
[rmsd] compared to 324 equivalent residues of the Dbs PH
domain with only 51% sequence similarity) (Figure S3A). An
analysis of protein sequence motifs and comparison of the
EhRGS-RhoGEF PH domain structure to other PH domains
in complex with phospholipid head groups (Ferguson et al.,
2000) revealed poor conservation of a potential phospholipid-
binding site on EhRGS-RhoGEF. Thus, we do not hypothesize, 65–75, January 8, 2013 ª2013 Elsevier Ltd All rights reserved 69
Table 1. Data Collection and Refinement Statistics for
Selenomethionine EhRGS-RhoGEF
EhRGS-RhoGEF




a, b, c (A˚) 86.1, 46.3, 142.6
a, b, g () 90, 104.2, 90
Peak
Wavelength (A˚) 0.97954
Resolution (A˚) 43.0–2.30 (2.32–2.30)a
No. unique reflections 46,832
Rmerge (%) 8.9 (58.4)
b
I / sI 18.5 (2.0)
Completeness (%) 98.8 (86.4)
Redundancy 4.3 (2.5)
Wilson B-factor (A˚2) 25.6
Refinement
Resolution (A˚) 43.0–2.30 (2.35–2.30)
No. reflections 46,587 (2,639)










Bond lengths (A˚) 0.008
Bond angles () 1.080
aValues in parentheses are for highest-resolution shell.
bAll data were collected from a single crystal.
Figure 4. The Structure of EhRGS-RhoGEFReveals Interrelationship
between RGS and DH/PH Domains
(A) The RGS domain (yellow) adopts a canonical nine-helix fold and interacts
with the DH domain (green) opposite from the predicted Rho binding site. The
linker between the RGS and DH domains wraps 180 around the DH domain
and contains a 15-residue a helix (termed the ‘‘inhibitory helix’’; red) that
engages both the conserved PH domain fold (orange) and the C-terminal
portion of the DH domain.
(B) The inhibitory helix, DH, and PH domains are superimposed with the
structure of Intersectin/Cdc42 (gray; PDB 1KI1). The conserved site of Rho
GTPase interaction, illustrated by a surface rendering of Cdc42, is obstructed
in the case of EhRGS-RhoGEF. The inhibitory helix lies entirely within the
space corresponding to Cdc42. In addition, the long a6 helix is continuous in
Intersectin and other RhoGEFs, but is segmented into two helices related by
an 90 angle in EhRGS-RhoGEF. The a6b helix both interacts with the
putative inhibitory helix and contributes to obstruction of the Rho binding site.
The EhRGS-RhoGEF PH domain is also predicted to interfere with Rho binding
in this inactive conformation.
Figure S3 contains an analysis of the PH domain and its DH domain interface.
Structure
EhRGS-RhoGEF Acts to Control Amoebic Pathogenesisthat the EhRGS-RhoGEF PH domain directly associates with
phospholipids.
The EhRGS-RhoGEF DH domain is most similar to that of in-
tersectin (Dali server Z-score 19.4; PDB 1KI1). Superposition of
Intersectin/Cdc42 (Snyder et al., 2002) and EhRGS-RhoGEF
highlights a number of DH domain structural differences (Fig-
ure 4B). The a6 helix of EhRGS-RhoGEF, which is the longest
of the Intersectin DH domain, is disrupted by a loop, giving rise
to two helices at 90 relative orientations (termed a6a and
a6b). The PH domain adopts a very different orientation relative
to the DH domain in EhRGS-RhoGEF as compared to Intersectin
(Figure 4B). The PH domain of RGS-RhoGEF directly obstructs
the putative Rho binding site, similar to a number of mammalian
RhoGEFs, e.g., Vav and Sos (Das et al., 2000). The DH and
PH domains of EhRGS-RhoGEF share a substantial interface
(1200 A˚2 buried surface area) that occurs predominantly
through hydrophobic interactions between the a7 helix of the
PH domain and the a3d, a4, a5, and a6b helices of the DH70 Structure 21, 65–75, January 8, 2013 ª2013 Elsevier Ltd All rightsdomain (Figure S3B). Particularly, the hydrophobic side chains
of Phe-393 andMet-397 project into an approximately triangular
concavity formed by helices a3d, a4, and a5 (Figure S3B). The
nature of the DH/PH domain interface suggests that the struc-
tural relationship between the two domains observed in the
crystal structure likely also exists in solution. However, additionalreserved
Figure 5. The EhRGS-RhoGEF Inhibitory Helix Engages Both the DH
and PH Domains
(A and B) The EhRGS-RhoGEF DH and PH domains share an interface with the
hydrophobic inhibitory helix residues Leu-164, Ile-167, Ile-168, Trp-175, and
the aromatic ring of Tyr-160 (gray sticks). Hydrogen-bond interactions and
peripheral ionic interactions, e.g., Lys-172$Asp-383 and Lys-161$Glu-511,
also contribute to this interface. N andC indicate the N- andC-terminal ends of
the inhibitory helix, respectively.
A 2Fo-Fc electron density map of the inhibitory helix is shown in Figure S4.
Structure
EhRGS-RhoGEF Acts to Control Amoebic Pathogenesiscontacts of each domain with the inhibitory helix may also be
necessary to maintain the observed DH and PH domain relation-
ship (Figure 5), and alternative conformations are also possible.
The Inhibitory Helix Coordinates Occlusion of the Rho
GTPase Binding Site
In the inactive state of EhRGS-RhoGEF, the inhibitory helix, the
a6b helix of the DH domain, and the PH domain all obstruct
the presumptive Rho GTPase interaction surface of the DH
domain (Figure 4), as predicted based on comparison with the
Intersectin/Cdc42 structure (Snyder et al., 2002). In fact,
the entire RGS-DH domain linker inhibitory helix lies within the
space occupied by the Rho GTPase substrate in numerous,
well-conserved Dbl family GEF/Rho interactions (Rossman and
Sondek, 2005). The inhibitory helix interacts with both the DH
and PH domains through a series of hydrophobic and polar inter-
actions (Figure 5 and S4). The hydrophobic residues Leu-164,
Ile-167, Ile-168, and Trp-175 interface with a hydrophobic patch
at the DH a6B helix/PH domain interface, consisting primarily ofStructure 21the hydrophobic portion of Lys-386, Leu-387, Ile-406, and Ile-
450 (Figure 5 and S4). Surrounding the hydrophobic patch are
a number of apparent polar and ionic interactions, including
those between Lys-161 of the inhibitory helix and Glu-511 of
the PH domain as well as Lys-172 and Asp-383 of the inhibitory
and DH domain a6B helices, respectively. The inhibitory helix
residues Lys-166 and Ile-170 also form limited contacts with
a DH domain loop from a neighboring molecule in the crystal
lattice (Figure S5C), but these contacts likely do not contribute
to the observed main chain conformation. Notably, the RGS-
DH linker containing the putative inhibitory helix is much shorter
in EhRGS-RhoGEF (26 residues) than the corresponding linker in
its mammalian homologs, with p115 RhoGEF possessing the
next shortest linker at 164 residues (Figure S1C). Thus, it is likely
that this region exhibits different structural features and poten-
tially performs different functions in mammalian RGS-RhoGEFs.
Convergent Evolution of the EhGa1/EhRGS-RhoGEF
Interface
The RGS/DH domain interface consists of a central hydrophobic
region with peripheral hydrogen bond and ionic interactions (Fig-
ure 6A and S4B). The residues corresponding to this domain
interface are not highly conserved among mammalian RGS-
RhoGEFs, such as p115 RhoGEF (Figure S1). This observation,
together with a previous SAXS analysis of the elongated p115
RhoGEF (Chen et al., 2012), suggests that the structural relation-
ships among the EhRGS-RhoGEF domains differ from those of
mammalian homologs.
The RGS domain of EhRGS-RhoGEF closely resembles the
nine-helix bundle found in canonical RGS domains, such as
RGS4 (Figure 6B). This canonical RGS domain fold is distinct
from the 12-helix rgRGS domains of mammalian RGS-RhoGEFs,
such as p115 (Figure 6C; Aittaleb et al., 2010). EhRGS-RhoGEF
is unique in possessing a canonical nine-helix RGS domain, sug-
gesting that the RGS and DH-PH domain combination within
E. histolytica may have arisen through an independent evolu-
tionary mechanism.
In addition to possessing a distinctive RGS domain fold, the
mammalian RGS-RhoGEFs engage Ga12/13 subunits through
an effector-like interface, primarily utilizing switch 2 and the a3
helix on Ga, although the N-terminal extension of the rgRGS
domain required for GAP activity also contacts the three
switches and the all-helical domain (Figure 7B; Aittaleb et al.,
2010). In contrast, canonical nine-helix RGS domains primarily
interface with Ga switches 1 and 2 (Figure 7A; Soundararajan
et al., 2008); hence, the Ga subunit switch 1 Gly-to-Ser ‘‘RGS-in-
sensitivity’’ mutation selectively disrupts canonical RGS domain
interactions, but not Ga/rgRGS domain interactions (Lan et al.,
1998; Meigs et al., 2005). To test whether the EhRGS-RhoGEF
RGS domain interfaces with EhGa1 in a canonical fashion,
we generated the EhGa1(G168S) mutant. EhRGS-RhoGEF ex-
hibited drastically lower affinity for EhGa1(G168S) than wild-
type EhGa1, as measured by surface plasmon resonance, and
was unable to affect the intrinsic GTPase rate of EhGa1(G168S)
(Figures 1B and 1G). These experiments suggest that the
EhGa1/EhRGS-RhoGEF interface most likely resembles a
canonical RGS/Ga interaction, providing further evidence for
an independent evolutionary mechanism giving rise to a Ga/
RGS-RhoGEF signaling axis in E. histolytica., 65–75, January 8, 2013 ª2013 Elsevier Ltd All rights reserved 71
Figure 6. The EhRGS-RhoGEF RGS Domain
Adopts a Canonical Fold and Interacts with
the DH Domain
(A) Residues participating in the RGS (yellow) and
DH (green) domain interface in EhRGS-RhoGEF
are shown in sticks. A central hydrophobic region
is surrounded by polar and ionic side chain inter-
actions. A 2Fo-Fc electron densitymap of the RGS/
DH interface is shown in Figure S4B.
(B) The EhRGS-RhoGEF RGS domain adopts a
nine-helical bundle fold very similar to canonical
RGS domains, typified by RGS4 (red; PDB 1AGR).
(C) In contrast, the mammalian RGS-RhoGEFs
possess an RGS-like domain with 12 helices, as
seen in p115 RGS-RhoGEF (PDB 1IAP). Dotted
lines indicate loops that could not be accurately
modeled.
Figure S5 illustrates crystal contacts of the RGS
domain and inhibitory helix.
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The E. histolytica Ga subunit is divergent in its amino acid
sequence as compared to mammalian Ga subunits and, in
particular, does not belong to the Ga12/13 subfamily that
couples to mammalian RGS-RhoGEFs (Figure S6). However,
EhGa1 does engage the RGS domain of EhRGS-RhoGEF in
a nucleotide state-dependent fashion, resulting in accelerated
GTP hydrolysis. A search of publicly available sequenced
genomes identified the RGS and DH-PH tandem domain com-
bination exclusively in metazoan species (e.g., C. elegans and
D. melanogaster) with the only nonmetazoan exception being
the Entamoeba species. Resistance of EhGa1 to conventional
Ga subfamily classification, the RGS4-like nine-helix RGS
domain fold of the EhRGS-RhoGEF N terminus, and the canon-
ical nature of the EhGa1/EhRGS-RhoGEF interface, as evi-
denced by the EhGa1(G168S), EhRGS-RhoGEF(N83A), and
EhRGS-RhoGEF(E39K) mutants, all suggest an evolutionary
origin independent of the Ga12/13/RGS-RhoGEF signaling axis
present in mammals.
Mammalian RGS-RhoGEFs are thought to achieve full activa-
tion through integration of multiple signals, including, but not
limited to, interactions with Ga12/13. For instance, Ga12-mediated
stimulation of leukemia-associated RhoGEF requires tyrosine
phosphorylation by Tec (Suzuki et al., 2003). Consistent with
this theme, EhRGS-RhoGEF requires coexpression, not only
with constitutively active EhGa1, but also with constitutively
active EhRacC, to achieve apparent activation, as evidenced
by S2 cell spreading. Little is currently known about EhRacC
signaling in E. histolytica, although it is evidently a substrate for
EhGEF2 in vitro (Gonza´lez De la Rosa et al., 2007). EhRacC
was seen to bind EhRGS-RhoGEF directly, exclusively in the
GTP-bound conformation, suggesting that EhRGS-RhoGEF72 Structure 21, 65–75, January 8, 2013 ª2013 Elsevier Ltd All rights reservedmay serve as an EhRacC effector. Acti-
vated human RhoA GTPase has been
demonstrated to bind the PH domain of
PDZ-RhoGEF in an analogous fashion
(Chen et al., 2010b). RhoA also serves
as a substrate for PDZ-RhoGEF-medi-ated exchange, suggesting a possible mode of feedback regula-
tion in mammals. However, there is currently no evidence that
EhRacC is a substrate for EhRGS-RhoGEF; in fact, EDTA-
treated, nucleotide-free EhRacC did not bind appreciably to
EhRGS-RhoGEF (Figure 2D). However, the full-length, isolated
EhRGS-RhoGEF used in these experiments is expected to
have an obstructed Rho substrate-binding site, and activation
by EhGa1$GTP, EhRacC$GTP, and/or other factors may be
required to allow efficient substrate binding. Although the puta-
tive exchange factor activity of EhRGS-RhoGEF was not directly
measureable, selective knockdown of endogenous D.m. Rac1/2
in S2 cells impaired the cell spreading triggered by coexpression
of EhRGS-RhoGEF, EhGa1(Q/L), and EhRacC(Q/L), suggesting
that Drosophila Rac may serve as a substrate for EhRGS-
RhoGEF in a cellular context. However, the cell spreading ex-
periments provide limited insight into the precise signaling
mechanics. For instance, additional cellular factors may con-
tribute to EhRGS-RhoGEF activation, and we cannot rule out
the possibility that overexpressed E. histolytica signaling com-
ponents promote cell spreading through other endogenous sig-
naling pathways.
In isolation, EhRGS-RhoGEF appears to adopt an autoinhi-
bited conformation, with direct obstruction of the presumptive
Rho substrate-binding surface by a putative inhibitory helix
and its DH and PH domain interactions. We hypothesize that
binding of EhGa1$GTP and EhRacC$GTP to EhRGS-RhoGEF,
possibly together with other cellular context factors, such as
membrane localization or posttranslational modifications, may
lead to a structural rearrangement of the putative inhibitory helix
and the PH domain, allowing for substrate Rho GTPase bind-
ing and nucleotide exchange. The predicted mode of EhRGS-
RhoGEF autoinhibition, as derived from the crystal structure, is
comparable to that ofmammalian PDZ-RhoGEF, seen in solution
Figure 7. Evolutionary Analysis of the EhGa1/EhRGS-RhoGEF Signaling Pathway
Canonical RGS domains, illustrated by RGS4 (PDB 1AGR), and rgRGS domains of mammalian RGS-RhoGEFs, represented by that of p115 (PDB 3AB3), exhibit
distinct folds.
(A) The EhRGS-RhoGEF RGS domain structure (yellow) closely resembles RGS4 (red), suggesting a canonical Ga/RGS domain interaction as exhibited by the
RGS4/Gai1 complex. Canonical RGS domains engage primarily switches 1 and 2, while rgRGS domains interact with the effector interface of Ga12/13 (orange)
family members, primarily through switch 2 and the a3 helix, although the N-terminal extension required for GAP activity also contacts the three switch regions
and the all-helical domain (B). The EhGa1(G168S), EhRGS-RhoGEF(E39K), and EhRGS-RhoGEF(N83A) mutations can distinguish between the two modes of
binding by selectively disrupting the canonical RGS domain binding site. Divergence of EhGa1 sequence from known mammalian subfamilies, together with the
canonical nine-helix RGS domain of EhRGS-RhoGEF and its mode of EhGa1 interaction, suggest that the EhGa1/RGS-RhoGEF signaling axis arose by an
evolutionary mechanism distinct from and functionally convergent with that of the mammalian Ga12/13/RGS-RhoGEF axis.
Figure S6 contains a comparison of EhGa1 to mammalian Ga subfamily members.
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RhoGEF, an acidic stretch of its rgRGS-DH domain linker inter-
acts with a DH domain surface basic cluster, distinct from the
inhibitory helix interface seen here in the crystal structure of
EhRGS-RhoGEF. The rgRGS-DH linker of p115 RhoGEF also
apparently inhibits the GEF activity of its DH-PH domain tandem,
although both SAXS analyses and crystallographic studies of the
DH-PH domains with short segments of the linker intact suggest
a different linker disposition than that seen in EhRGS-RhoGEF
(Chen et al., 2011). The RGS-DH linker in EhRGS-RhoGEF
is >100 residues shorter than those of mammalian homologs
(Figure S1C), further suggesting that this region does not have
a conserved structure across species.
Endogenous EhRGS-RhoGEF likely represents a functional
signaling link between heterotrimeric G-proteins and Rho family
GTPases in E. histolytica. Indeed, Rho GTPases and other Dbl
family RhoGEFs in E. histolytica are also known to regulate
multiple processes important for pathogenesis, such as actin re-
organization during chemotaxis, surface receptor capping, cell
killing, phagocytosis, and tissue destruction (Guille´n, 1996). A
surprisingly large family of Rho GTPases (>20 members) is
apparently simultaneously expressed in the single-celled para-
site (Bosch et al., 2011a). Further studies are needed to deter-
mine which Rho family members are activated by EhRGS-
RhoGEF and what downstream signaling pathways are utilized.
Overexpression of EhRGS-RhoGEF resulted in reduced
E. histolytica trophozoite chemotactic migration, attachment to
and killing of host cells, and secretion of cysteine proteases.
By each of these measures, the EhRGS-RhoGEF trophozoiteStructure 21strain phenocopies a strain overexpressing a dominant negative
EhGa1 point mutant and exhibits an opposing trend to trophozo-
ites overexpressing wild-type EhGa1 (Bosch et al., 2012), con-
sistent with ectopically overexpressed EhRGS-RhoGEF serving
to accelerate GTP hydrolysis on EhGa1 and thus inhibit its
signaling. Given the amenability of heterotrimeric G protein sig-
naling to pharmacological manipulation (Gilchrist, 2007), this
pathway provides a promising drug target for the treatment of
amoebic colitis.EXPERIMENTAL PROCEDURES
Cloning and Protein Purification
See Supplemental Experimental Procedures.
Crystallization and Structure Determination
Crystals of the full-length EhRGS-RhoGEF (aa 1–519) yielded diffraction
data not suitable for either molecular replacement or anomalous dispersion.
However, by removing two residues on both the N- and C-termini of
EhRGS-RhoGEF, we obtained another crystal form with improved diffraction
quality, ultimately allowing structure determination by SAD. Crystallization
was achieved by hanging drop vapor diffusion at 18C. EhRGS-RhoGEF at
15mg/ml in crystallization buffer (50 mM4-(2-hydroxyethyl)-1-piperazineetha-
nesulfonic acid [HEPES] pH 7.5, 100 mM NaCl, and 1 mM dithiothreitol) was
mixed 1:1 and equilibrated against crystallization solution containing 16%
(w/v) polyethylene glycol 3350 and 100 mM sodium malonate pH 5.0. Hexag-
onal plate crystals grew to 400 3 150 3 20 mm over 5 days. EhRGS-RhoGEF
crystals displayed the symmetry of space group C2 (a = 86.1 A˚, b = 46.3 A˚, c =
142.6 A˚, a = g = 90, b = 104.2), with one monomer in the asymmetric unit.
Prior to data collection, crystals were cryoprotected in crystallization solution
supplemented with 25% (v/v) glycerol., 65–75, January 8, 2013 ª2013 Elsevier Ltd All rights reserved 73
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nium absorption peak) and 100 K temperature at the GM/CA-CAT ID-D beam-
line (APS, Argonne National Labs) and processed using HKL2000 (Otwinowski
and Minor, 1997). A highly redundant data set was obtained combining partial
data sets from five points along the EhRGS-RhoGEF plate crystal. Heavy atom
searching identified eight of eight possible sites, and refinement yielded an
estimated Bayes correlation coefficient of 48.2 to 2.5 A˚ resolution. After
density modification, the estimated Bayes correlation coefficient increased
to 66.0. Approximately 75% of the model was constructed automatically,
and the remaining portion was built manually. The current model (Table 1)
contains one EhRGS-RhoGEF monomer.
Refinement was carried out against peak anomalous data with Bijvoet pairs
kept separateusingphenix.refine (Adamset al., 2010) interspersedwithmanual
model revisions using the program Coot (Emsley and Cowtan, 2004) and con-
sisted of conjugate-gradient minimization and calculation of individual atomic
displacement and translation/libration/screw parameters (Painter and Merritt,
2006). Residues that could not be identified in the electron density were: 1,
139, 140, 153–156, and 452–454. The model exhibits excellent geometry, as
determined byMolProbity (Chen et al., 2010a). A Ramachandran analysis iden-
tified 97.6% favored, 2.4% allowed, and 0%disallowed residues. Coordinates
and structure factors are deposited in the RCSB Protein Data Bank (4GOU).
Single Turnover Nucleotide Hydrolysis
GTP hydrolysis by single turnover assays was quantified as previously
described (Bosch et al., 2011b). For GTPase acceleration assays, increasing
concentrations of purified EhRGS-RhoGEF were added along with the hydro-
lysis-initiating magnesium.
Surface Plasmon Resonance
Optical detection of protein binding was conducted as described previously
(Kimple et al., 2010). Briefly, His6-tagged wild-type or mutant EhRGS-RhoGEF
was immobilized on an nitrilotriacetic acid (NTA) chip surface by capture
coupling and increasing concentrations of wild-type EhGa1, and mutants
were flowed over at 10 ml/s in various nucleotide states. In complementary
experiments, glutathione S-transferase (GST)-EhGa1 was immobilized on an
anti-GST chip surface, as described (Hutsell et al., 2010), and increasing
concentrations of EhRGS-RhoGEF and mutants flowed over.
NTA Affinity Coprecipitation
See Supplemental Experimental Procedures.
Trophozoite Stable Transfection
See Supplemental Experimental Procedures.
Chemotactic Migration
Trophozoite migration assays were performed essentially as described previ-
ously (Gilchrist et al., 2008). Briefly, amoebae harvested in log growth phase
were suspended in serum-free trypticase yeast extract iron growth medium
and50,000 cells loaded in the upper chamberof a Transwellmigrationchamber
(Costar, 8 mm pore size). The lower chamber contained growth medium with
or without 15% adult bovine serum. Transwell plates were incubated at 37C
for 2 hr under anaerobic conditions (GasPak EZ, BD Biosciences).
Host Cell Attachment
Attachment of E. histolytica trophozoites to epithelial monolayers was as-
sessed as previously described (Shrimal et al., 2010). CHO cells were grown
to confluency in 24 well plates, washed, and fixed in 4% paraformaldehyde
for 30 min. Trophozoites (3 3 105) were added to the fixed monolayers in
medium 199 supplemented with 5.7 mM cysteine, 1 mM ascorbic acid, and
25 mM HEPES (pH 6.9). After incubation at 37C for 30 min, each well was
washed gently two times with warm PBS to remove unattached trophozoites.
Monolayer-attached trophozoites were quantified by counting with an inverted
microscope. Each experiment was performed in quadruplicate and statistical
significance determined by Student’s t test.
Cell Killing
Killing of mammalian cells (Jurkat) was assessed using the CytoTox-ONE
membrane integrity assay (Promega). In 96-well plates, 5 3 105 Jurkat cells74 Structure 21, 65–75, January 8, 2013 ª2013 Elsevier Ltd All rightsand/or 2.5 3 105 trophozoites were incubated at 37C in 200 ml of medium
199 (Sigma) supplemented with 5.7 mM cysteine, 0.5% BSA, and 25 mM
HEPES pH 6.8. After 2 hr, 50 ml of medium from each well was incubated
with Cytotox reagent, and a colorimetric measure of extracellular lactate
dehydrogenase activity was obtained after 10 min. Each experiment was per-
formed in quadruplicate and statistical significance determined by Student’s
t test.
Cysteine Protease Activity
See Supplemental Experimental Procedures.
S2 Cell Culture and Spreading Assay
S2 cells were obtained from the Drosophila Genome Resource Center (Bloo-
mington, IL), and cultivated as described previously (Rogers and Rogers,
2008). S2 cells were maintained in SF900 SFM (Invitrogen, Carlsbad, CA)
and transfected with 2 mg total DNA using the Amaxa nucleofector system
(Lonza, Basel, Switzerland). Expression of transfected constructs was induced
with 35 mM CuSO4. Double-stranded RNAs (see Supplemental Experiment
Procedures for primers) were produced using a Promega (Madison, WI) Ribo-
max T7 kit according to manufacturer instructions. S2 cells at 50%–90% con-
fluency in six-well plates were treated every other day for 7 days with 7.5 mg/ml
of double-stranded RNA. On day 5 of RNA interference (RNAi) treatment, cells
were transfected as above and then induced on day 6. Cells were resus-
pended and plated on poly-L-lysine (Sigma-Aldrich, St. Louis, MO)-coated
coverslips and allowed to spread for 1 hr. For quantifying numbers of cells
with spreading, each condition was repeated at least three times and R100
cells were counted per experiment.
Immunofluorescence Microscopy
See Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes one table, six figures, and Supplemental
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